Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 6/2017

01-06-2017 | Original Contributions

Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up

Authors: Valerio Ceriani, Francesco Cetta, Tiziana Lodi, Ferdinando Pinna, Antonio E. Pontiroli

Published in: Obesity Surgery | Issue 6/2017

Login to get access

Abstract

Background

Biliopancreatic diversion (BPD) is a bariatric technique burdened, in some instances, by clinical evidence of malabsorption and malnutrition, and by intractable diarrhea.

Objective

The objective of this study was to assess metabolic and nutritional effects on patients undergoing BPD and BPD plus revisional surgery because of side effects.

Methods

Thirty-five consecutive BPD patients underwent revisional surgery (elongation of the common limb from 50 to 200 cm and reduction of the gastric pouch from 500 to 40 ml) after a median 48-month period [48.3 ± 9.17 months (mean ± SD)] and were observed for a total period of 116.2 ± 6.21 months; 88 patients only undergoing BPD (controls) were observed for 120 months.

Results

Revisional surgery significantly improved side effects of BPD, with resolution of clinical symptoms in most instances. After revisional surgery, patients had a further decrease of body weight. The effect on disappearance of diabetes mellitus (DM) was remarkable, with no difference between revisional surgery and BPD. Triglycerides and transaminases decreased in a similar way, while cholesterol levels differed significantly. Estimated glomerular filtration rate improved. Nutritional parameters were similarly affected.

Conclusion

This study suggests that it is possible to maintain the clinical and metabolic effects of BPD after a revisional procedure that leads to lesser malabsorption and to a greater restriction of the stomach. In particular, the positive effects on DM still persist after revisional surgery. This approach should be kept in mind in the presence of significant side effects due, inter alia, to excessive malabsorption.
Literature
1.
Alvarez-Cordero R. Treatment of clinically severe obesity—a public health problem: introduction. World J Surg. 1998;22:905–6.CrossRefPubMed
2.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed
3.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRefPubMed
4.
Keshishian A, Zahriya K, Willes EB. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Obes Surg. 2005;15:1418–23.CrossRefPubMed
5.
Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84.CrossRefPubMed
6.
Aller R, Pacheco D, Izaola O, et al. Effect on liver enzymes of biliopancreatic diversion: 4 years of follow-up. Ann Nutr Metab. 2015;66:132–6.CrossRefPubMed
7.
Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16:1278–86.CrossRefPubMed
8.
Gastaldelli A, Perego L, Paganelli M, et al. Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding. Obes Surg. 2009;19:80–6.CrossRefPubMed
9.
Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis. 2010;28:274–9.CrossRefPubMed
10.
Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;2013:839275.CrossRefPubMedPubMedCentral
11.
Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495.CrossRefPubMedPubMedCentral
12.
Folini L, Veronelli A, Benetti A, et al. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding. Acta Diabetol. 2014;51:361–8.CrossRefPubMed
13.
Hassanian M, Al-Mulhim A, Al-Sabhan A, et al. The effect of bariatric surgeries on nonalcoholic fatty liver disease. Saudi J Gastroenterol. 2014;20:270–8.CrossRefPubMedPubMedCentral
14.
Scopinaro N. Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg. 2006;16:683–9.CrossRefPubMed
15.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.CrossRefPubMed
16.
Ceriani V, Pinna F, Lodi T, Gaffuri P. Revisional surgery: biliopancreatic diversion failure. In: M. Lucchese, N. Scopinaro (eds): Bariatric and Metabolic Mini-Invasive Surgery. Principles and Technical Aspects, Springer, 2015, pp 257–266.
17.
18.
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?. Diabetes Care. 2009;32:2133–5.
19.
Levey AS, Coresh J, Greene T, et al. Chronic kidney disease epidemiology C. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.CrossRefPubMed
20.
Hakeam HA, O'Regan PJ, Salem AM, et al. Impact of laparoscopic sleeve gastrectomy on iron indices: 1 year follow-up. Obes Surg. 2009;19:1491–6.CrossRefPubMed
21.
Varma S, Baz W, Badine E, et al. Need for parenteral iron therapy after bariatric surgery. Surg Obes Relat Dis. 2008;4:715–9.CrossRefPubMed
22.
Obinwanne KM, Fredrickson KA, Mathiason MA, et al. Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis. J Am Coll Surg. 2014;218:246–52.CrossRefPubMed
23.
Ferrer R, Pardina E, Rossell J, et al. Haematological parameters and serum trace elements in “healthy” and “unhealthy” morbidly obese patients before and after gastric bypass. Clin Nutr. 2015;34:276–83.CrossRefPubMed
24.
Schuster DP, Teodorescu M, Mikami D, et al. Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis. 2011;7:459–64.CrossRefPubMed
25.
Agrawal V, Krause KR, Chengelis DL, et al. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis. 2009;5:20–6.CrossRefPubMed
26.
Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011;34:561–7.CrossRefPubMedPubMedCentral
27.
Jose B, Ford S, Super P, et al. The effect of biliopancreatic diversion surgery on renal function—a retrospective study. Obes Surg. 2013;23:634–7.CrossRefPubMed
28.
Ruiz-Tovar J, Giner L, Sarro-Sobrin F, et al. Laparoscopic sleeve gastrectomy prevents the deterioration of renal function in morbidly obese patients over 40 years. Obes Surg. 2015;25:796–9.CrossRefPubMed
29.
Ballesteros-Pomar MD, González de Francisco T, Urioste-Fondo A, et al. Biliopancreatic diversion for severe obesity: long-term effectiveness and nutritional complications. Obes Surg. 2016;26:38–44.CrossRefPubMed
30.
Marceau P, Biron S, Marceau S, et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes Surg. 2015;25:1584–93.CrossRefPubMed
31.
Thurnheer M, Bisang P, Ernst B, et al. A novel distal very long Roux-en Y gastric bypass (DVLRYGB) as a primary bariatric procedure—complication rates, weight loss, and nutritional/ metabolic changes in the first 355 patients. Obes Surg. 2012;22:1427–36.CrossRefPubMed
32.
Svanevik M, Risstad H, Hofsø D, et al. Perioperative outcomes of proximal and distal gastric bypass in patients with BMI ranged 50-60 kg/m2. A double-blind, randomized controlled trial. Obes Surg. 2015;25:1788–95.CrossRefPubMedPubMedCentral
33.
Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg. 1997;1:517–24.CrossRefPubMed
34.
Brolin RE, LaMarca LB, Kenler HA, et al. Malabsorptive gastric bypass in patients with super-obesity. J Gastrointest Surg. 2002;6:195–203.CrossRefPubMed
35.
Ceriani V, Cetta F, Pinna F, et al. Abnormal calcium, 25(OH)vitamin D, and parathyroid hormone after biliopancreatic diversion; correction through elongation of the common tract and reduction of the gastric pouch. Surgery for Obesity and Related Diseases, Surg Obes Relat Dis. 2016;12:805–12.CrossRefPubMed
36.
Busetto L, Sbraccia P, Frittitta L, et al. The growing role of bariatric surgery in the management of type 2 diabetes: evidences and open questions. Obes Surg. 2011;21:1451–7.CrossRefPubMed
37.
Salehi M, D'Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15:171–9.CrossRefPubMedPubMedCentral
38.
Frige' F, Laneri M, Veronelli A, et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis. 2009;19:198–204.CrossRefPubMed
39.
Pontiroli AE, Laneri M, Veronelli A, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol. 2009;8:37.CrossRefPubMedPubMedCentral
40.
Benetti A, Del Puppo M, Crosignani A, et al. Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures. Diabetes Care. 2013;36:1443–7.CrossRefPubMedPubMedCentral
41.
Currò G, Centorrino T, Cogliandolo A, et al. A clinical and nutritional comparison of biliopancreatic diversion performed with different common and alimentary channel lengths. Obes Surg. 2015;25:45–9.CrossRefPubMed
Metadata
Title
Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up
Authors
Valerio Ceriani
Francesco Cetta
Tiziana Lodi
Ferdinando Pinna
Antonio E. Pontiroli
Publication date
01-06-2017
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2479-3

Other articles of this Issue 6/2017

Obesity Surgery 6/2017 Go to the issue

Original Contributions

A New Algorithm to Reduce the Incidence of Gastroesophageal Reflux Symptoms after Laparoscopic Sleeve Gastrectomy.

Erratum

Erratum to: Intraoperative Patterns of Gastric Microperfusion During Laparoscopic Sleeve Gastrectomy

Letter to the Editor

The Mechanism of Metabolic Surgery: Gastric Center Hypothesis: Letter to the Editor

Original Contributions

Can We Predict the Perioperative Pulmonary Complications Before Laparoscopic Sleeve Gastrectomy: Original Research

Original Contributions

Post-implant Analysis of Epidemiologic and Eating Behavior Data Related to Weight Loss Effectiveness in Obese Patients Treated with Gastric Electrical Stimulation

Original Contributions

Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy as Revisional Procedures after Adjustable Gastric Band: 5-Year Outcomes